and here's why documentation is NRs' achilles heel on an
and here's why documentation is NRs' achilles heel on an OTC target that outlasts
NRs' *efforts* .. in P2O's case it's 10 years
suspect ETRF has a compliance issue on PTOI .. they shut down their *bid* last week
of course i also know from actual P2O investors who use certain *firms* .. that their GTCs
get utilized upon occasion .. even when they are cash accts ..
contrary to what NRs' .. er .. *efforts* .. post
last month .. if memory serves .. word was sent to me that a brokerage firm
that always *routed* PTOI buys/bids .. via NITE .. had switched to CDEL
.. this was confirmed by at least 2 other *actual* P2O investors .. b4 being
changed out .. for a week or so
so why in the last month would some MMs (who have always abusively shorted PTOI)
change *tactics*?
the last aspect any NR entity wants known is what gets done .. let's not forget
the author of the first hit piece on P2O (July 2010) .. spent years promoting
bogus bs 24/7/365 via the vehicle of choice for OTC stock manipulation that
there was no such thing as an OTC *stock* being *shorted* (legal or abusive)
that *scenario* of course had to be *adjusted* when Finra's link (at the behest
of the SEC) first went live back in Feb 2010 .. but i digress
NRs' issue goes back directly to the first *run* on PTOI in December 2009
for the most part .. i tend to only *focus* on what NR has *done* since P2O was
wrested back in mid August 2013
the biggest asset P2O has besides the founder's tech and company's enviable
share structure .. remains P2O's actual early/original investors .. many of whom
have never sold one share of PTOI
NRs' *dilemma* remains a settlement issue with P2O's ability to execute (first
sale with monies exchanged)
4kids
1
Plastic2Oil, Inc. (PTOI) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...
Continue Reading
The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...
Continue Reading
Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...
Continue Reading
In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...
Continue Reading
Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...
Continue Reading
The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...
Continue Reading
IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...
Continue Reading
Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...
Continue Reading
Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...
Continue Reading
Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...
Continue Reading
Top 5 Most Recently Viewed Articles
Leadership Change at Church & Dwight Church & Dwight Co., Inc. (NYSE: CHD) is poised for an important change with the announcement of a leadership transition that will significantly impact the future of the company. The Board of Directors has confirmed that Richard Dierker, who has enjoyed a successful 15-year tenure with the company, will assume the role of President and...
Continue Reading
Artesian Resources Corporation Increases Dividend by 2% Artesian Resources Corporation (NASDAQ: ARTNA) recently announced an exciting update for its shareholders: a 2% increase in the quarterly common stock dividend. This decision was made by the Board of Directors and reflects the company's ongoing commitment to financial stability and shareholder satisfaction. The...
Continue Reading
World Living Soils Forum: A New Era for Soil Protection In a world increasingly focused on sustainability, the preservation and regeneration of our soils have become paramount. The second edition of the World Living Soils Forum is set to take place at LUMA Arles, aiming to unite visionaries and innovators dedicated to soil health. Making an Impact Together This...
Continue Reading
TNL Mediagene Achieves Market Recognition TNL Mediagene's remarkable performance in the recent awards showcases the strength and innovative spirit of its three companies. The Agency & Advertiser of the Year Awards 2024 highlighted their collective achievements, demonstrating a significant leadership position in news media, marketing technology, data services, and policy...
Continue Reading
Investors Take Action Against Lineage, Inc. for IPO Misrepresentation Investors holding shares of Lineage, Inc. (NASDAQ: LINE) are now taking a united stand against the company, as substantial concerns arise regarding the integrity of its Initial Public Offering (IPO). Wolf Haldenstein Adler Freeman & Herz LLP is leading the charge in a class action lawsuit aimed at...
Continue Reading